12:00 AM
 | 
Nov 11, 2013
 |  BC Week In Review  |  Financial News  |  Amended Offerings

Cytos amends rights offering

Cytos Biotechnology AG (SIX:CYTN), Schlieren, Switzerland
Business: Neurology, Inflammation, Infectious
Date announced: 11/5/13
Type: Rights offering
To be raised: Up to CHF17.6 million ($19.3 million)
Shares outstanding prior: 22.4...

Read the full 123 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >